Abstract
Alterations in 3D chromatin conformation may disrupt the interplay between promoters and distal enhancers. How gene regulatory circuits are reshaped during ionizing radiation-induced tumorigenesis remains unclear. This study performed ATAC-seq, RNA-seq, and Hi-C analyses of human bronchial epithelial cells and corresponding radiation-induced malignant transformed cell lines. We identified tumour protein 63 (TP63) as a mediator of new chromatin-accessible sites that anchor tumour-specific chromatin contacts. A TP63-mediated accessible chromatin site anchors a tumour-specific TAD boundary and multiple tumour-specific chromatin loops, which underlie MYC oncogene activation during malignant transformation.
Introduction
Ionizing radiation is a well-established driver of lung cancer, primarily through the induction of DNA double-strand breaks. However, the mechanism by which these transient events translate into a permanent malignant program remains a subject of intense research. Recent evidence suggests that the three-dimensional (3D) organization of the genome—the chromatin architecture—is fundamental to gene regulation. This study investigates how radiation reshapes this architecture and identifies the specific molecular mediators that drive these structural changes.
Methodology
The researchers employed a comprehensive multi-omics approach to compare normal human bronchial epithelial cells (BEP2D) with their radiation-transformed malignant counterparts (BERP35T1/T4). Key techniques included:
- Hi-C and Micro-C: To map the 3D genomic wiring diagram at high resolution.
- ATAC-seq: To identify "open" vs. "closed" regions of chromatin.
- RNA-seq: To measure changes in gene expression.
- CUT&Tag: To pinpoint the binding sites of structural proteins (CTCF, Cohesin) and the candidate mediator TP63.
- Validation: Overexpression of TP63 in normal cells was used to test its ability to recreate the cancer-specific genomic architecture.
Results
Large-scale Chromatin Reorganization
Malignant transformation was characterized by a significant shift of DNA from the inactive "B compartment" to the active "A compartment," affecting approximately 9.7% of the genome. This reorganization was accompanied by an increase in the number of Topologically Associating Domains (TADs), indicating the formation of new structural boundaries in the tumor cells.
TP63 as a Pioneer Factor
Through motif enrichment analysis of gained ATAC-seq peaks, the researchers identified TP63 as the primary driver of these changes. Unlike standard transcription factors, TP63 acts as a "pioneer factor," penetrating closed chromatin to open it and subsequently recruiting structural proteins like CTCF and Cohesin. This process creates new chromatin-accessible sites that anchor tumor-specific contacts.
The MYC Oncogene Hub
A critical discovery occurred at the MYC locus. In tumor cells, TP63 binds to a site approximately 340kb upstream of MYC, anchoring a new TAD boundary and a "hub" of chromatin loops. These loops funnel enhancer activity directly to the MYC promoter, driving a five-fold increase in its expression compared to normal cells. Overexpressing TP63 in normal cells was sufficient to recreate these specific loops and induce MYC activation.
Discussion and Clinical Relevance
The TP63-occupied sites identified in this study overlap significantly with binding sites found in clinical Lung Squamous Cell Carcinoma (LUSC) data, suggesting that this mechanism is highly relevant to human disease. While the study clarifies how TP63 rewires the genome, the initial trigger for stable TP63 upregulation following radiation exposure remains to be explored. Future research in animal models and human cohorts will be essential to validate these findings as potential therapeutic targets for radiation-induced lung cancer.
Data Availability: Sequencing data is deposited in the GEO database under accession GSE175860.
Summary updated